Products & ReviewClinical Diagnostics

Lyme Disease Diagnostic Tests

EUROIMMUNAvailable: Worldwide

EUROIMMUN’s Lyme disease portfolio includes all tests for qualified two-tiered borreliosis diagnostics according to current recommendations. Antibody screening and confirmatory tests are based on optimised combinations of native and recombinant antigens, including early- and late-stage markers and exclusive antigens. Specialised CSF assays support diagnosis of neuroborreliosis. Scalable automation solutions are available.

Request Pricing
EUROIMMUN

Receive your quote directly from the manufacturer.

Ease of Use
After Sales Service
Value for Money
Write your own review
  • Broad range of Lyme disease screening (ELISA, ChLIA) and confirmatory (EUROLINE, EUROMicroblot, EUROLINE-WB) tests available
  • Antigen portfolio includes VlsE from different Borrelia species, dimeric recombinant OspC advanced, p39 (BmpA), p83, p41, p58, p21, p20, p19, p18 and immunogenic lipids
  • Parallel automated processing of ELISA and EUROMicroblot on the same instrument enables efficient high-throughput analyses
  • Measurement of CXCL13 and intrathecal antibodies using CSF assays aids diagnosis of neuroborreliosis

Product Overview

Links